SEC Form 3 · accession 0001829126-26-010085
Veraxa Biotech AG - Post de-SPAC · VRXA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Raju Sudir Willener
Officer — Chief Financial Officer
Period of report
Sep 1, 2026
Accepted (ET)
Sep 14, 2026 · 4:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0002079109
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
No Table II lines on this filing.